TUESDAY, June 3, 2025 (HealthDay News) — Starting breast cancer screening in women’s early 40s will save more lives, a new study argues. Nearly 3 in 4 women (73%) in their 40s find out they have breast cancer only after they’ve developed symptoms, researchers reported May 30 in the journalContinue Reading
MONDAY, June 2, 2025 (HealthDay News) — A structured exercise program helped colon cancer survivors live longer and lowered their odds for a relapse, a major international study shows. The program lasted three years and included regular meetings with a fitness coach, Associated Press reported. Over the period, people inContinue Reading
MONDAY, June 2, 2025 (HealthDay News) — U.S. rural communities could be experiencing a “brain drain” when it comes to cancer care, a new study says. Most new radiation oncologists — docs who treat cancer with radiation — are choosing to work in big metropolitan areas rather than in ruralContinue Reading
MONDAY, June 2, 2025 (HealthDay News) — Wildfire smoke could make it harder for people with lung cancer to survive, a new study says. Californians with lung cancer who breathed smoke from wildfires had a 20% increased risk of dying from their cancer, researchers reported Saturday at the American SocietyContinue Reading
WEDNESDAY, May 28, 2025 (HealthDay News) — Thanks to artificial intelligence (AI), more women might soon benefit from targeted breast cancer treatment, a new study says. AI can help identify women who might be helped by cancer therapies that target HER2, a protein that spurs on the growth of tumorContinue Reading
WEDNESDAY, May 28, 2025 (HealthDay News) — Higher temperatures spurred by climate change could be increasing women’s risk of cancer, a new study says. Increasing heat in the Middle East and North Africa has made breast, ovarian, uterine and cervical cancers more common and more deadly, researchers reported May 26Continue Reading
WEDNESDAY, May 28, 2025 (HealthDay News) — Popular GLP-1 weight loss drugs like Ozempic and Zepbound can help reduce a woman’s risk for as many as 14 cancers associated with obesity, a new study says. People taking a GLP-1 drug had a 7% lower risk of developing an obesity-related cancerContinue Reading
TUESDAY, May 27, 2025 (HealthDay News) — The last thing a cancer patient might like to do is hit the treadmill or hop on an exercise bike, given how much the disease and its treatments drain a person’s energy. But toughing through regular workouts can boost their odds of beatingContinue Reading
FRIDAY, May 23, 2025 (HealthDay News) — Former President Joe Biden’s prostate cancer diagnosis has drawn attention to screening guidelines for older men. When Biden, 82, was diagnosed last week, his cancer had already spread to his bones. His last prostate screening was more than a decade ago. “President Biden’sContinue Reading
FRIDAY, May 23, 2025 (HealthDay News) — Alcohol-fueled cancer deaths nearly doubled in the United States during the past three decades, with cases among men driving this surge, a new study says. Between 1990 and 2021, deaths from alcohol-related cancers leaped from just under 12,000 deaths per year to justContinue Reading
THURSDAY, May 22, 2025 (HealthDay News) — Louise Duffield, 60, was relieved to receive a normal mammogram result in 2023, but agreed to undergo an additional MRI scan recommended as part of a clinical trial. Her mammogram showed she had very dense breasts, which can sometimes prevent detection of breastContinue Reading
The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapyContinue Reading
MONDAY, May 19, 2025 (HealthDay News) — Former President Joe Biden has been diagnosed with advanced prostate cancer that has spread to his bones, his office announced Sunday. Doctors found the cancer after Biden reported urinary symptoms. Testing showed a small nodule on his prostate. His medical team said theContinue Reading
MONDAY, May 19, 2025 (HealthDay News) — Cutting-edge GLP-1 weight-loss drugs appear to help lower cancer risk even beyond the benefits from dropping excess pounds, a new study says. First-generation GLP-1 drugs like liraglutide (Saxenda) and exenatide (Byetta) were associated with a 41% lower risk of obesity-related cancers, compared withContinue Reading